关于 PSMA 靶向放射性配体的白蛋白结合与肿瘤蓄积之间关系的基础评估

IF 2.5 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Nobuki Kazuta, Shohei Tsuchihashi, Hiroyuki Watanabe, Masahiro Ono
{"title":"关于 PSMA 靶向放射性配体的白蛋白结合与肿瘤蓄积之间关系的基础评估","authors":"Nobuki Kazuta,&nbsp;Shohei Tsuchihashi,&nbsp;Hiroyuki Watanabe,&nbsp;Masahiro Ono","doi":"10.1007/s12149-024-01930-8","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>The marked success of prostate-specific membrane antigen (PSMA)-targeting radioligands with albumin binder (ALB) is attributed to the improvement of blood retention and tumor accumulation. [<sup>111</sup>In]In-PNT-DA1, our PSMA-targeting radioligand with ALB, also achieved improved tumor accumulation due to its prolonged blood retention. Although the advantage of ALBs is related to their reversible binding to albumin, the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands remains unclear because of the lack of information about radioligands with stronger albumin-binding than ALBs. In this study, we designed and synthesized [<sup>111</sup>In]In-PNT-DM-HSA, a new radioligand that consists of a PSMA-targeting radioligand covalently bound to albumin. The pharmacokinetics of [<sup>111</sup>In]In-PNT-DM-HSA was compared with those of [<sup>111</sup>In]In-PNT-DA1 and [<sup>111</sup>In]In-PSMA-617, a non-ALB-conjugated radioligand, to evaluate the relationship between albumin-binding and tumor accumulation.</p><h3>Method</h3><p>The [<sup>111</sup>In]In-PNT-DM-HSA was prepared by incubation of [<sup>111</sup>In]In-PNT-DM, a PSMA-targeting radioligand including a maleimide group, and human serum albumin (HSA). The ability of [<sup>111</sup>In]In-PNT-DM-HSA was evaluated by in vitro assays. A biodistribution study using LNCaP tumor-bearing mice was conducted to compare the pharmacokinetics of [<sup>111</sup>In]In-PNT-DM-HSA, [<sup>111</sup>In]In-PNT-DA1, and [<sup>111</sup>In]In-PSMA-617.</p><h3>Results</h3><p>The [<sup>111</sup>In]In-PNT-DM-HSA was obtained at a favorable radiochemical yield and high radiochemical purity. In vitro assays revealed that [<sup>111</sup>In]In-PNT-DM-HSA had fundamental characteristics as a PSMA-targeting radioligand interacting with albumin covalently. In a biodistribution study, [<sup>111</sup>In]In-PNT-DM-HSA and [<sup>111</sup>In]In-PNT-DA1 showed higher blood retention than [<sup>111</sup>In]In-PSMA-617. On the other hand, the tumor accumulation of [<sup>111</sup>In]In-PNT-DA1 was much higher than [<sup>111</sup>In]In-PNT-DM-HSA and [<sup>111</sup>In]In-PSMA-617.</p><h3>Conclusions</h3><p>These results indicate that the moderate reversible binding of ALB with albumin, not covalent binding, may play a critical role in enhancing the tumor accumulation of PSMA-targeting radioligands.</p></div>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":"38 7","pages":"574 - 583"},"PeriodicalIF":2.5000,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fundamental evaluation regarding the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands\",\"authors\":\"Nobuki Kazuta,&nbsp;Shohei Tsuchihashi,&nbsp;Hiroyuki Watanabe,&nbsp;Masahiro Ono\",\"doi\":\"10.1007/s12149-024-01930-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>The marked success of prostate-specific membrane antigen (PSMA)-targeting radioligands with albumin binder (ALB) is attributed to the improvement of blood retention and tumor accumulation. [<sup>111</sup>In]In-PNT-DA1, our PSMA-targeting radioligand with ALB, also achieved improved tumor accumulation due to its prolonged blood retention. Although the advantage of ALBs is related to their reversible binding to albumin, the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands remains unclear because of the lack of information about radioligands with stronger albumin-binding than ALBs. In this study, we designed and synthesized [<sup>111</sup>In]In-PNT-DM-HSA, a new radioligand that consists of a PSMA-targeting radioligand covalently bound to albumin. The pharmacokinetics of [<sup>111</sup>In]In-PNT-DM-HSA was compared with those of [<sup>111</sup>In]In-PNT-DA1 and [<sup>111</sup>In]In-PSMA-617, a non-ALB-conjugated radioligand, to evaluate the relationship between albumin-binding and tumor accumulation.</p><h3>Method</h3><p>The [<sup>111</sup>In]In-PNT-DM-HSA was prepared by incubation of [<sup>111</sup>In]In-PNT-DM, a PSMA-targeting radioligand including a maleimide group, and human serum albumin (HSA). The ability of [<sup>111</sup>In]In-PNT-DM-HSA was evaluated by in vitro assays. A biodistribution study using LNCaP tumor-bearing mice was conducted to compare the pharmacokinetics of [<sup>111</sup>In]In-PNT-DM-HSA, [<sup>111</sup>In]In-PNT-DA1, and [<sup>111</sup>In]In-PSMA-617.</p><h3>Results</h3><p>The [<sup>111</sup>In]In-PNT-DM-HSA was obtained at a favorable radiochemical yield and high radiochemical purity. In vitro assays revealed that [<sup>111</sup>In]In-PNT-DM-HSA had fundamental characteristics as a PSMA-targeting radioligand interacting with albumin covalently. In a biodistribution study, [<sup>111</sup>In]In-PNT-DM-HSA and [<sup>111</sup>In]In-PNT-DA1 showed higher blood retention than [<sup>111</sup>In]In-PSMA-617. On the other hand, the tumor accumulation of [<sup>111</sup>In]In-PNT-DA1 was much higher than [<sup>111</sup>In]In-PNT-DM-HSA and [<sup>111</sup>In]In-PSMA-617.</p><h3>Conclusions</h3><p>These results indicate that the moderate reversible binding of ALB with albumin, not covalent binding, may play a critical role in enhancing the tumor accumulation of PSMA-targeting radioligands.</p></div>\",\"PeriodicalId\":8007,\"journal\":{\"name\":\"Annals of Nuclear Medicine\",\"volume\":\"38 7\",\"pages\":\"574 - 583\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-04-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Nuclear Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s12149-024-01930-8\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Nuclear Medicine","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12149-024-01930-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

目的 含有白蛋白粘合剂(ALB)的前列腺特异性膜抗原(PSMA)靶向放射性配体的显著成功归功于血液滞留和肿瘤蓄积的改善。我们的[111In]In-PNT-DA1是含有ALB的PSMA靶向放射性配体,由于其血液滞留时间长,因此也能改善肿瘤蓄积。虽然 ALB 的优势与其与白蛋白的可逆性结合有关,但由于缺乏比 ALB 更强的白蛋白结合性放射性配体的信息,PSMA 靶向放射性配体的白蛋白结合与肿瘤蓄积之间的关系仍不清楚。在这项研究中,我们设计并合成了[111In]In-PNT-DM-HSA,这是一种新的放射性配体,由与白蛋白共价结合的PSMA靶向放射性配体组成。将[111In]In-PNT-DM-HSA的药代动力学与[111In]In-PNT-DA1和[111In]In-PSMA-617(一种非白蛋白结合的放射性配体)的药代动力学进行了比较,以评估白蛋白结合与肿瘤蓄积之间的关系。方法将含有马来酰亚胺基团的 PSMA 靶向放射性配体 [111In]In-PNT-DM 与人血清白蛋白(HSA)孵育,制备 [111In]In-PNT-DM-HSA 。体外试验评估了 [111In]In-PNT-DM-HSA 的能力。结果[111In]In-PNT-DM-HSA以良好的放射化学收率和较高的放射化学纯度获得。体外实验表明,[111In]In-PNT-DM-HSA 具有与白蛋白共价作用的 PSMA 靶向放射性配体的基本特征。在生物分布研究中,[111In]In-PNT-DM-HSA和[111In]In-PNT-DA1比[111In]In-PSMA-617显示出更高的血液滞留率。结论这些结果表明,ALB 与白蛋白的适度可逆结合而非共价结合可能在增强 PSMA 靶向放射性配体的肿瘤蓄积方面发挥了关键作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Fundamental evaluation regarding the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands

Fundamental evaluation regarding the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands

Fundamental evaluation regarding the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands

Objective

The marked success of prostate-specific membrane antigen (PSMA)-targeting radioligands with albumin binder (ALB) is attributed to the improvement of blood retention and tumor accumulation. [111In]In-PNT-DA1, our PSMA-targeting radioligand with ALB, also achieved improved tumor accumulation due to its prolonged blood retention. Although the advantage of ALBs is related to their reversible binding to albumin, the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands remains unclear because of the lack of information about radioligands with stronger albumin-binding than ALBs. In this study, we designed and synthesized [111In]In-PNT-DM-HSA, a new radioligand that consists of a PSMA-targeting radioligand covalently bound to albumin. The pharmacokinetics of [111In]In-PNT-DM-HSA was compared with those of [111In]In-PNT-DA1 and [111In]In-PSMA-617, a non-ALB-conjugated radioligand, to evaluate the relationship between albumin-binding and tumor accumulation.

Method

The [111In]In-PNT-DM-HSA was prepared by incubation of [111In]In-PNT-DM, a PSMA-targeting radioligand including a maleimide group, and human serum albumin (HSA). The ability of [111In]In-PNT-DM-HSA was evaluated by in vitro assays. A biodistribution study using LNCaP tumor-bearing mice was conducted to compare the pharmacokinetics of [111In]In-PNT-DM-HSA, [111In]In-PNT-DA1, and [111In]In-PSMA-617.

Results

The [111In]In-PNT-DM-HSA was obtained at a favorable radiochemical yield and high radiochemical purity. In vitro assays revealed that [111In]In-PNT-DM-HSA had fundamental characteristics as a PSMA-targeting radioligand interacting with albumin covalently. In a biodistribution study, [111In]In-PNT-DM-HSA and [111In]In-PNT-DA1 showed higher blood retention than [111In]In-PSMA-617. On the other hand, the tumor accumulation of [111In]In-PNT-DA1 was much higher than [111In]In-PNT-DM-HSA and [111In]In-PSMA-617.

Conclusions

These results indicate that the moderate reversible binding of ALB with albumin, not covalent binding, may play a critical role in enhancing the tumor accumulation of PSMA-targeting radioligands.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Annals of Nuclear Medicine
Annals of Nuclear Medicine 医学-核医学
CiteScore
4.90
自引率
7.70%
发文量
111
审稿时长
4-8 weeks
期刊介绍: Annals of Nuclear Medicine is an official journal of the Japanese Society of Nuclear Medicine. It develops the appropriate application of radioactive substances and stable nuclides in the field of medicine. The journal promotes the exchange of ideas and information and research in nuclear medicine and includes the medical application of radionuclides and related subjects. It presents original articles, short communications, reviews and letters to the editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信